New Wonder Drug Successful in Treating COVID-19
A new Covid-19 drug has been found to prevent 100 per cent of symptomatic infections during trials on the NHS.
The promising results suggest that the experimental antibody cocktail, developed by Regeneron Pharmaceuticals Inc, could be used as a “passive vaccine” to block coronavirus.
Patients who took part in the trial, run with the National Institute of Allergy and Infectious Diseases (NIAID), were injected with the antibody cocktail, called REGEN-COV, which is made up of lab-enhanced antibodies that are designed to mimic how the body would respond to an invading virus.
The drug was administered to people who had been exposed to coronavirus from someone in their household, with the trial showing that the antibodies stopped symptomatic cases entirely.